Latest Articles
- Is a pound of prevention better than an ounce of prevention?
With statins, should we “start low and go slow” or adopt a new paradigm?
- Statins: The case for higher, individualized starting doses
We’re not getting our patients’ low-density lipoprotein cholesterol down to goal levels. We would do better by starting at a higher dose if the patient has a higher baseline level.
- Managing short bowel syndrome: Making the most of what the patient still has
Eating and drinking are better than parenteral nutrition.
Auto-positive end-expiratory pressure: Mechanisms and treatmentThis common problem in mechanical ventilation increases the work of breathing, worsens gas exchange, and decreases cardiac output.
- Emerging care for type 2 diabetes: Using insulin to reach lower glycemic goals
Experts are advocating earlier, more aggressive treatment of type 2 diabetes.
- Dose-related statin myopathy: Is it an issue?
Higher doses lead to more cases of myopathy, a potentially serious problem. Fortunately, the incidence is very low.
- Alopecia areata: What to expect from current treatments
Alopecia areata often resolves on its own, but some treatment is often needed due to the psychosocial impact.
- Angiotensin-receptor blockers: Benefits beyond lowering blood pressure
These drugs improve the prognosis more than one would expect from their effect on blood pressure alone.